Dr. Raymond Stein recently spoke at the Canadian Ophthalmological Society’s annual meeting, which took place in Toronto. He was asked to discuss a new corneal laser treatment for age-related macular degeneration (AMD) that was recently approved by Health Canada.

Dr. Stein, who is the medical director at Bochner Eye Institute, associate professor of ophthalmology at the University of Toronto and Vision Sciences and a cornea, refractive and cataract surgery specialist, is excited to share this innovative technology with fellow ophthalmologists and patients that find their vision limited by wet or dry AMD. So far, data indicates this corneal laser offers the best chance of enhancing vision and improving quality of life with AMD.

Laser Treatment for AMD

The new corneal laser treatment is recommended for both wet and dry AMD patients, as well as patients with other macular conditions like Stargardt disease, macular holes and Best Disease.

With dry AMD, the more common and milder form of the disease, small yellow deposits of debris called drusen form under the retina, and the retina starts to thin and dry out. Dry AMD typically causes minimal visual impairment. Without treatment, it can progress to wet AMD, which is characterized by the growth of abnormal blood vessels under the retina and macula. These blood vessels can leak blood and fluid, and gradually distort or destroy central vision.

The new corneal laser modifies the cornea to re-direct light to the back of the eye to a location outside the blind spot. The procedure is very well tolerated and according to Dr. Stein, there has been no reported patient discomfort during or after the procedure. After closely monitoring patients that had the treatment, Dr. Stein and his colleagues found that both distance and near vision continued to improve over a three-year period after the laser procedure.

Bochner Eye Institute First Centre in North America to Offer the Technology

Always at the forefront of advances in ophthalmology technology, Bochner Eye Institute is the first centre in North America to offer this innovative treatment. Dr. Stein and his colleagues are currently accepting referrals for consultation at their four facilities in downtown Toronto, Scarborough, Oakville and Unionville.

More about the Canadian Ophthalmological Society

The Canadian Ophthalmological Society hosted their annual meeting May 31-June 3, 2018 at the Metro Toronto Centre. More than 600 ophthalmologists and 300 allied health professionals gathered to listen to 19 international keynote speakers and 55 sessions covering breakthrough developments in ophthalmology.

If you are interested in learning more about Bochner Eye Institute’s work with laser treatment for AMD, please contact one of our offices by calling (416) 960-2020 to schedule a consultation.